Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pau Castel

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Cancer Discovery|September 9, 2016
Systematic Functional Characterization of Resistance to PI3K Inhibition in Breast CancerXiuning Le, Rajee Antony, Pedram Razavi, et al.
The EMBO Journal|November 1, 2016
The hVps34-SGK3 pathway alleviates sustained PI3K/Akt inhibition by stimulating mTORC1 and tumour growthRuzica Bago, Eeva Sommer, Pau Castel, et al.
The EMBO Journal|August 3, 2016
The hVps34-SGK3 pathway alleviates sustained PI3K/Akt inhibition by stimulating mTORC1 and tumour growthRuzica Bago, Eeva Sommer, Pau Castel, et al.
The Journal of Biological Chemistry|May 6, 2023
The ribosomal S6 kinase 2 (RSK2)-SPRED2 complex regulates the phosphorylation of RSK substrates and MAPK signalingJocelyne Lopez, Daniel A Bonsor, Matthew J Sale, et al.
Science (New York, N.Y.)|March 16, 2019
RIT1 oncoproteins escape LZTR1-mediated proteolysisPau Castel, Alice Cheng, Antonio Cuevas-Navarro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2016
Therapeutic Benefit of Selective Inhibition of p110α PI3-Kinase in Pancreatic Neuroendocrine TumorsAdriana Soler, Ana M Figueiredo, Pau Castel, et al.
Iscience|August 20, 2024
The deubiquitinase USP9X regulates RIT1 protein abundance and oncogenic phenotypesAmanda K Riley, Michael Grant, Aidan Snell, et al.
Science Translational Medicine|April 1, 2016
Somatic PIK3CA mutations as a driver of sporadic venous malformationsPau Castel, F Javier Carmona, Joaquim Grego-Bessa, et al.
Science (New York, N.Y.)|March 25, 2017
PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2DEneda Toska, Hatice U Osmanbeyoglu, Pau Castel, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2021
RAS interaction with Sin1 is dispensable for mTORC2 assembly and activityPau Castel, Srisathiyanarayanan Dharmaiah, Matthew J Sale, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Cancer Discovery|September 9, 2016
Systematic Functional Characterization of Resistance to PI3K Inhibition in Breast CancerXiuning Le, Rajee Antony, Pedram Razavi, et al.
The EMBO Journal|November 1, 2016
The hVps34-SGK3 pathway alleviates sustained PI3K/Akt inhibition by stimulating mTORC1 and tumour growthRuzica Bago, Eeva Sommer, Pau Castel, et al.
The EMBO Journal|August 3, 2016
The hVps34-SGK3 pathway alleviates sustained PI3K/Akt inhibition by stimulating mTORC1 and tumour growthRuzica Bago, Eeva Sommer, Pau Castel, et al.
The Journal of Biological Chemistry|May 6, 2023
The ribosomal S6 kinase 2 (RSK2)-SPRED2 complex regulates the phosphorylation of RSK substrates and MAPK signalingJocelyne Lopez, Daniel A Bonsor, Matthew J Sale, et al.
Science (New York, N.Y.)|March 16, 2019
RIT1 oncoproteins escape LZTR1-mediated proteolysisPau Castel, Alice Cheng, Antonio Cuevas-Navarro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2016
Therapeutic Benefit of Selective Inhibition of p110α PI3-Kinase in Pancreatic Neuroendocrine TumorsAdriana Soler, Ana M Figueiredo, Pau Castel, et al.
Iscience|August 20, 2024
The deubiquitinase USP9X regulates RIT1 protein abundance and oncogenic phenotypesAmanda K Riley, Michael Grant, Aidan Snell, et al.
Science Translational Medicine|April 1, 2016
Somatic PIK3CA mutations as a driver of sporadic venous malformationsPau Castel, F Javier Carmona, Joaquim Grego-Bessa, et al.
Science (New York, N.Y.)|March 25, 2017
PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2DEneda Toska, Hatice U Osmanbeyoglu, Pau Castel, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2021
RAS interaction with Sin1 is dispensable for mTORC2 assembly and activityPau Castel, Srisathiyanarayanan Dharmaiah, Matthew J Sale, et al.
Pageof 6